PHARMACOLOGICALLY BASED PHASE-I TRIALS IN CANCER-CHEMOTHERAPY

被引：12

作者：

NEWELL, DR

机构：

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1994年 / 8卷 / 02期

关键词：

D O I：

10.1016/S0889-8588(18)30172-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：257 / 275

页数：19

共 65 条

[51] PHARMACODYNAMICS IN CANCER-THERAPY [J].

RATAIN, MJ ;

SCHILSKY, RL ;

CONLEY, BA ;

EGORIN, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) :1739-1753

[52]

RELLING MV, 1992, CANCER CHEMOTHERAPY, V7, P287

[53]

SCHER HI, 1992, CANCER RES, V52, P64

[54] ANTICANCER DRUG SCREENING AND DISCOVERY IN THE 1990S - A EUROPEAN PERSPECTIVE [J].

SCHWARTSMANN, G ;

WORKMAN, P .

EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) :3-14

[55] A PHASE-I AND PHARMACOKINETIC STUDY OF AMPHETHINILE [J].

SMITH, DB ;

EWEN, C ;

MACKINTOSH, J ;

FOX, BW ;

THATCHER, N ;

SCARFFE, JH ;

VEZIN, R ;

CROWTHER, D .

BRITISH JOURNAL OF CANCER, 1988, 57 (06) :623-627

[56]

SMITH DB, 1987, CANCER TREAT REP, V71, P817

[57] A PHASE-I STUDY OF META-AZIDOPYRIMETHAMINE ETHANESULFONATE (MZPES) - A NEW DIHYDROFOLATE-REDUCTASE INHIBITOR [J].

STUART, NSA ;

CRAWFORD, SM ;

BLACKLEDGE, GRP ;

NEWLANDS, ES ;

SLACK, J ;

HOFFMAN, R ;

STEVENS, MFG .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (05) :308-310

[58] A PHASE-1 AND PHARMACOKINETIC STUDY OF DIDOX - A RIBONUCLEOTIDE REDUCTASE INHIBITOR [J].

VEALE, D ;

CARMICHAEL, J ;

CANTWELL, BMJ ;

ELFORD, HL ;

BLACKIE, R ;

KERR, DJ ;

KAYE, SB ;

HARRIS, AL .

BRITISH JOURNAL OF CANCER, 1988, 58 (01) :70-72

[59]

Von Hoff DD, 1984, CANC CLIN TRIALS MET, P210

[60]

WEBBER SE, IN PRESS J MED CHEM

← 1 2 3 4 5 6 7 →